LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is “highly effective” and “considered to be of …
Read More »Tag Archives: twiceyearly
EU regulator backs Gilead's twice-yearly injection for HIV prevention – Reuters
EU regulator backs Gilead’s twice-yearly injection for HIV prevention Reuters E.U. regulator approves injectable HIV drug that experts say could help stop transmission NBC News EU regulators back twice-yearly HIV injection Euronews.com Yeztugo approval: A new era in HIV prevention Newsday Expert: Lenacapavir Shows 100% Efficacy in Key Trial, Offering Transformative Twice-Yearly HIV Prevention Pharmacy Times Source link
Read More »EU regulators back twice-yearly HIV injection – Euronews.com
EU regulators back twice-yearly HIV injection Euronews.com EU regulator backs Gilead’s twice-yearly injection for HIV prevention Reuters EU regulator approves injectable HIV drug that experts say could help stop transmission PBS Yeztugo approval: A new era in HIV prevention Newsday Does six-monthly PrEP have a future following the collapse of global HIV funding? Aidsmap Source link
Read More »WHO recommends Gilead's twice-yearly injection for HIV prevention – Reuters
WHO recommends Gilead’s twice-yearly injection for HIV prevention Reuters WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight CNN Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis World Health Organization (WHO) Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost STAT WHO urges rollout of first …
Read More »